Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.
| Image |  |
|---|---|
| Description | scientific article published on 16 June 2016 |
| Author/s |
author: Gamal E. Shiha Mohamed Hassany Imam Waked Mohamed A Mohey Reham Soliman |
| Publication date | June 16, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |